Aaron Kirchfeld is the Executive Editor Global Deals at Bloomberg News. He specializes in aviation and aerospace, covering topics such as drone technology, commercial and private airlines, alongside finance and trading in the energy and mining sectors. Aaron's work has been featured in prominent publications including the Sunday Times, Business Day, and Fortune.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Aaron Kirchfeld's coverage predominantly revolves around business and finance, particularly focusing on private equity, mergers and acquisitions, investment banking, and IPOs. He seems to have a strong interest in covering news related to major deals within the financial sector.
If you are looking to reach out effectively to Aaron Kirchfeld, consider providing insights or exclusive information related to significant corporate transactions such as M&A activities, private equity investments or exits, as well as developments in the IPO market. Additionally, if your company is involved in major financial dealings or strategic decisions within these realms of interest covered by Aaron Kirchfeld's articles he may be interested in hearing from you.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Wall Street bank cements position on top of league tables, but rivals have taken top billing on recent deals including ITV
By: Sylvia Pfeifer, Aaron Kirchfeld
Calls by EU for structural concessions while also seeking European consolidation would be ‘absurd’ says Lorenzo Mariani
By: Aaron Kirchfeld, Sylvia Pfeifer
As drones and autonomous systems transform the battlefield, traditional defence companies start to act more like venture capitalists
By: Attracta Mooney, Aaron Kirchfeld
Schneider Electric and Heineken are among large groups rolling out measures to protect workers as extreme weather intensifies
By: Oliver Barnes, Arash Massoudi, James Fontanella-Khan, Aaron Kirchfeld
Tie-up would create one of the world’s biggest drugmakers
By: Aanu Adeoye, Aaron Kirchfeld
Mike Doustdar says he is open to ‘large’ deals and group will suffer ‘failures’ as it tries to cut reliance on weight-loss drugs
By: Aanu Adeoye, Aaron Kirchfeld
One year since becoming Novo Nordisk's chief executive, Mike Doustdar is betting on the “phenomenal” sales of its weight-loss pill, new
By: Aaron Kirchfeld, Emma Dunkley, Aanu Adeoye, Oliver Barnes, James Fontanella-Khan, Patrick Temple-West
A merger between the giant drugmakers would have marked a return to pharma megadeals
By: Aaron Kirchfeld, Olaf Storbeck
Martin Blessing says foreign investors face sceptical public authorities
By: Aaron Kirchfeld
Potential disposal comes after company announced deal with Leonardo and Thales
